Skip to main content

AnswerThis

AnswerThis provides an AI-powered research workflow platform that verifies every citation and claim against a database of 300M+ papers, trials, and PDFs. Researchers can upload drafts or ask questions to receive grounded, cited answers, with support for systematic reviews, meta-analysis, and PRISMA-compliant workflows. The platform consolidates search, notes, references, and writing into a single tool used by over 200,000 institutions and individuals.

Traction 10/10
University of Richmond, United States · HQ
Founded 2023910K+ followers
  • Artificial Intelligence
  • Data & Analytics
  • AI Agents
  • Software Only
Updated 7 days ago

Funding

Raised to date

$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Researchers waste weeks manually screening thousands of papers before writing a single line of their work. AI tools often produce inconsistent or fabricated citations that cannot be traced to source material, and juggling separate tools for search, notes, references, and writing causes context loss and slows the entire research process.

Solution

AnswerThis provides an AI-powered research workflow platform that auto-evaluates every citation and claim against a database of 300M+ papers, trials, and PDFs. Users can upload a draft or ask a question to receive grounded, cited answers in multiple citation styles, with each source and statement verified against the paper it came from so nothing unverified reaches the draft. The platform consolidates search, notes, references, and writing into one workflow, and supports agent-led systematic reviews with PRISMA compliance, meta-analysis with GRADE certainty, trial landscape mapping, and regulatory-grade connectors. Research teams use AnswerThis to create submissions up to 10x faster, with every step logged and exportable for regulators.

Target Audience

Primary customers are academic researchers, students, doctors, and scientific teams at universities, hospitals, and biopharma companies, including HEOR, pharma, and CRO organizations conducting systematic reviews, meta-analyses, and trial landscape assessments.

Features

  • Auto-verification of every source and claim against 300M+ papers, trials, and PDFs, ensuring traceability to original passages
  • Agent-led systematic review and PRISMA-compliant workflows with dual/AI reviewer screening, living reviews, and full audit trails
  • Meta-analysis with fixed or random-effects models, network meta-analysis with SUCRA rankings, and GRADE certainty grading
  • Trial Landscape mapping for any target, indication, or modality, with phase/status, sponsor, and endpoint tracking from live trial registries
  • Deep search across 250M+ papers with connectors to PubMed, Embase, Cochrane, regulatory filings, and medical databases
  • AI Writer for full manuscript drafting, plus export to Zotero, Mendeley, and EndNote, and shared workspaces for collaborative teams
  • Frontier models with no rate caps on higher tiers, and citation styles including APA, MLA, Chicago, and more
This profile is AI-generated and may contain inaccuracies.